Xenetic Biosciences (XBIO) Misses Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts XBIO Hot Sheet
Join SI Premium – FREE
Xenetic Biosciences (NASDAQ: XBIO) reported Q1 EPS of ($0.34), $0.13 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Xenetic Biosciences (XBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- Driven Brands (DRVN) Tops Q4 EPS by 2c, Misses on Revenue; Offers FY26 Guidance
- Cracker Barrel (CBRL) Tops Q3 EPS by 71c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
